Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 23 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 8314125

    Bicyclic derivatives as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  2. US 8314239

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  3. US 8314256

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Nov 20, 2012 · Expires Nov 15, 2032

    granted
  4. US 8309587

    Piperidine and piperazine phenyl sulphonamides as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  5. US 8309543

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  6. US 8304414

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  7. US 8304423

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Nov 6, 2012 · Expires Nov 1, 2032

    granted
  8. US 8299099

    Heteroaryl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted
  9. US 8293929

    Processes and intermediates

    Vertex Pharmaceuticals Incorporated · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted
  10. US 8288400

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  11. US 8288537

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 16, 2012 · Expires Oct 11, 2032

    granted
  12. US 8278306

    C-met protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  13. US 8278297

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 2, 2012 · Expires Sep 27, 2032

    granted
  14. US 8273896

    Processes for producing phenyl-6-(1-(phenyl)ureido)nicotinamides

    Vertex Pharmaceuticals Incorporated · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted
  15. US 8268873

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  16. US 8268811

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  17. US 8268818

    Inhibitors of C-MET and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  18. US 8268829

    Substituted pyrimidines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  19. US 8269013

    Substituted pyrazole inhibitors of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  20. US 8268999

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  21. US 8269012

    Aminopyrazole triazolothiadiazole inhibitors of c-met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  22. US 8269026

    Lupane derivatives useful for treating HIV

    Vertex Pharmaceuticals Incorporated · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted
  23. US 8263777

    Aminopyrazole triazolothiadiazole inhibitor of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  24. US 8263776

    Inhibitors of c-Met protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted